Insider Trading Alert - AHC, AKRX And CNBKA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 12, 2014, 103 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $33.00 to $9,071,220.00.

Highlighted Stocks Traded by Insiders:

A H Belo (AHC) - FREE Research Report

Blizzard Daniel J, who is Senior Vice Pres & Secretary at A H Belo, sold 10,034 shares at $12.37 on Dec. 12, 2014. Following this transaction, the Senior Vice Pres & Secretary owned 0 shares meaning that the stake was reduced by 100% with the 10,034-share transaction.

The shares most recently traded at $12.26, down $0.11, or 0.9% since the insider transaction. Historical insider transactions for A H Belo go as follows:

  • 4-Week # shares bought: 1,880
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 1,880
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 1,880
  • 24-Week # shares sold: 48,000

The average volume for A H Belo has been 52,600 shares per day over the past 30 days. A H Belo has a market cap of $241.0 million and is part of the services sector and media industry. Shares are up 63.19% year-to-date as of the close of trading on Thursday.

A. H. Belo Corporation operates as a newspaper publishing, and local news and information company primarily in the United States. It owns and operates three metropolitan daily newspapers and related Web sites. The stock currently has a dividend yield of 2.59%. The company has a P/E ratio of 10.3. Currently, there are no analysts who rate A H Belo a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AHC - FREE

TheStreet Quant Ratings rates A H Belo as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, notable return on equity and reasonable valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full A H Belo Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Akorn (AKRX) - FREE Research Report

Graves Adrienne L, who is Director at Akorn, sold 9,557 shares at $41.09 on Dec. 12, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 9,557-share transaction.

The shares most recently traded at $41.24, up $0.15, or 0.36% since the insider transaction. Historical insider transactions for Akorn go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 24,311
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 24,311
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 29,311

The average volume for Akorn has been 1.5 million shares per day over the past 30 days. Akorn has a market cap of $4.4 billion and is part of the health care sector and drugs industry. Shares are up 65.96% year-to-date as of the close of trading on Thursday.

Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. The company has a P/E ratio of 203.0. Currently, there are 7 analysts who rate Akorn a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AKRX - FREE

TheStreet Quant Ratings rates Akorn as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and premium valuation. Get the full Akorn Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Century Bancorp (CNBKA) - FREE Research Report

Filler James J, who is 10% Owner at Century Bancorp, bought 27 shares at $39.50 on Dec. 12, 2014. Following this transaction, the 10% Owner owned 388,864 shares meaning that the stake was boosted by 0.01% with the 27-share transaction.

Historical insider transactions for Century Bancorp go as follows:

  • 4-Week # shares bought: 9
  • 12-Week # shares bought: 30
  • 24-Week # shares bought: 71

The average volume for Century Bancorp has been 5,200 shares per day over the past 30 days. Century Bancorp has a market cap of $142.2 million and is part of the financial sector and banking industry. Shares are up 18.77% year-to-date as of the close of trading on Thursday.

Century Bancorp, Inc. operates as the bank holding company for Century Bank and Trust Company that provides banking products and services to commercial enterprises, state and local governments and agencies, nonprofit organizations, and individuals in Massachusetts. The stock currently has a dividend yield of 1.22%. The company has a P/E ratio of 10.3.

Exclusive Offer: Get the latest Stock Analysis on CNBKA - FREE

TheStreet Quant Ratings rates Century Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, expanding profit margins, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Century Bancorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers